180 related articles for article (PubMed ID: 24906473)
1. Socioeconomic status and epithelial ovarian cancer survival in Sweden.
Weiderpass E; Oh JK; Algeri S; Bellocco R
Cancer Causes Control; 2014 Aug; 25(8):1063-73. PubMed ID: 24906473
[TBL] [Abstract][Full Text] [Related]
2. Predictors of ovarian cancer survival: a population-based prospective study in Sweden.
Yang L; Klint A; Lambe M; Bellocco R; Riman T; Bergfeldt K; Persson I; Weiderpass E
Int J Cancer; 2008 Aug; 123(3):672-9. PubMed ID: 18498135
[TBL] [Abstract][Full Text] [Related]
3. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study.
Kolomeyevskaya NV; Szender JB; Zirpoli G; Minlikeeva A; Friel G; Cannioto RA; Brightwell RM; Grzankowski KS; Moysich KB
Int J Gynecol Cancer; 2015 Nov; 25(9):1587-92. PubMed ID: 26273932
[TBL] [Abstract][Full Text] [Related]
4. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
5. Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group.
Altman AD; Lambert P; Love AJ; Turner D; Lotocki R; Dean E; Popowich S; Nachtigal MW
Int J Gynecol Cancer; 2017 Oct; 27(8):1637-1644. PubMed ID: 28704327
[TBL] [Abstract][Full Text] [Related]
6. Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer - a population-based study.
Anuradha S; Donovan PJ; Webb PM; Brand AH; Goh J; Friedlander M; Oehler MK; Quinn M; Steer C; Jordan SJ
Acta Oncol; 2016; 55(2):226-33. PubMed ID: 26079434
[TBL] [Abstract][Full Text] [Related]
7. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.
Mascarenhas C; Lambe M; Bellocco R; Bergfeldt K; Riman T; Persson I; Weiderpass E
Int J Cancer; 2006 Dec; 119(12):2907-15. PubMed ID: 16998830
[TBL] [Abstract][Full Text] [Related]
8. Impact of community disadvantage and air pollution burden on geographic disparities of ovarian cancer survival in California.
Vieira VM; Villanueva C; Chang J; Ziogas A; Bristow RE
Environ Res; 2017 Jul; 156():388-393. PubMed ID: 28395243
[TBL] [Abstract][Full Text] [Related]
9. The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.
Brewer KC; Peterson CE; Davis FG; Hoskins K; Pauls H; Joslin CE
Ann Epidemiol; 2015 Aug; 25(8):556-63. PubMed ID: 25986734
[TBL] [Abstract][Full Text] [Related]
10. Do stage of disease, comorbidity or access to treatment explain socioeconomic differences in survival after ovarian cancer? - A cohort study among Danish women diagnosed 2005-2010.
Ibfelt EH; Dalton SO; Høgdall C; Fagö-Olsen CL; Steding-Jessen M; Osler M; Johansen C; Frederiksen K; Kjær SK
Cancer Epidemiol; 2015 Jun; 39(3):353-9. PubMed ID: 25841586
[TBL] [Abstract][Full Text] [Related]
11. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery.
Paulsen T; Kærn J; Tropé C
Gynecol Oncol; 2011 Jul; 122(1):83-8. PubMed ID: 21435701
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of marital status on survival of women with epithelial ovarian cancer.
Mahdi H; Kumar S; Munkarah AR; Abdalamir M; Doherty M; Swensen R
Psychooncology; 2013 Jan; 22(1):83-8. PubMed ID: 21919121
[TBL] [Abstract][Full Text] [Related]
13. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study.
Anuradha S; Webb PM; Blomfield P; Brand AH; Friedlander M; Leung Y; Obermair A; Oehler MK; Quinn M; Steer C; Jordan SJ
Med J Aust; 2014 Sep; 201(5):283-8. PubMed ID: 25163381
[TBL] [Abstract][Full Text] [Related]
14. An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.
Wang KC; Chang WH; Lee WL; Huang N; Huang HY; Yen MS; Guo CY; Wang PH
BMC Cancer; 2014 Nov; 14():831. PubMed ID: 25403543
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer diagnosis and mortality by tumor stage and migration background in a nationwide cohort study in Sweden.
Abdoli G; Bottai M; Sandelin K; Moradi T
Breast; 2017 Feb; 31():57-65. PubMed ID: 27810701
[TBL] [Abstract][Full Text] [Related]
16. Costs of treatment for elderly women with advanced ovarian cancer in a Medicare population.
Forde GK; Chang J; Ziogas A; Tewari K; Bristow RE
Gynecol Oncol; 2015 Jun; 137(3):479-84. PubMed ID: 25866323
[TBL] [Abstract][Full Text] [Related]
17. Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume center.
Cowan RA; Tseng J; Ali N; Dearie H; Murthy V; Gennarelli RL; Iasonos A; Abu-Rustum NR; Chi DS; Long Roche KC; Brown CL
Gynecol Oncol; 2018 Apr; 149(1):43-48. PubMed ID: 29605049
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
Shuang T; Wang M; Zhou Y; Shi C
Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
[TBL] [Abstract][Full Text] [Related]
19. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.
Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M
Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725
[TBL] [Abstract][Full Text] [Related]
20. Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.
Bešević J; Gunter MJ; Fortner RT; Tsilidis KK; Weiderpass E; Onland-Moret NC; Dossus L; Tjønneland A; Hansen L; Overvad K; Mesrine S; Baglietto L; Clavel-Chapelon F; Kaaks R; Aleksandrova K; Boeing H; Trichopoulou A; Lagiou P; Bamia C; Masala G; Agnoli C; Tumino R; Ricceri F; Panico S; Bueno-de-Mesquita HB; Peeters PH; Jareid M; Quirós JR; Duell EJ; Sánchez MJ; Larrañaga N; Chirlaque MD; Barricarte A; Dias JA; Sonestedt E; Idahl A; Lundin E; Wareham NJ; Khaw KT; Travis RC; Rinaldi S; Romieu I; Riboli E; Merritt MA
Br J Cancer; 2015 Dec; 113(11):1622-31. PubMed ID: 26554655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
